‘Insourcing’ jobs to US could mean tax breaks for drug makers
This article was originally published in Scrip
Executive Summary
US drug makers could be among those that stand to gain from new tax incentives President Barack Obama plans to unveil in the coming weeks aimed at rewarding firms that bring jobs back into the US, while those that move jobs overseas will see certain tax advantages eliminated.